{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:31:56Z","timestamp":1760189516989,"version":"3.40.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"crossref","award":["NT-12363-4\/2011"],"award-info":[{"award-number":["NT-12363-4\/2011"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.imlet.2016.09.004","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T20:17:11Z","timestamp":1473884231000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Predictive value of serum cytokine levels in chronic myeloid leukemia patients"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3580-7790","authenticated-orcid":false,"given":"Martina","family":"Petrackova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Hamsikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Duskova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavlina","family":"Ptackova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Klamova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Humlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Vonka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2016.09.004_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1099-1069(199812)16:4<143::AID-HON628>3.0.CO;2-U","article-title":"Abnormal levels of proinflammatory cytokines in serum and monocyte cultures from patients with chronic myeloid leukemia in different stages, and their role in prognosis","volume":"16","author":"Anand","year":"1998","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.imlet.2016.09.004_bib0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/gtmb.2014.0011","article-title":"Prognostic importance of single-nucleotide polymorphisms in IL-6, IL-10, TGF-beta1, IFN-gamma, and TNF-alpha genes in chronic phase chronic myeloid leukemia","volume":"18","author":"Pehlivan","year":"2014","journal-title":"Genet. Test Mol. Biomark."},{"key":"10.1016\/j.imlet.2016.09.004_bib0015","first-page":"772","article-title":"Estimation of level of soluble form PECAM-1, ICAM-2 and TNF-alpha, IL-18 in serum patients with chronic myelogenic leukemia","volume":"62","author":"Kiersnowska-Rogowska","year":"2005","journal-title":"Przegl. Lek."},{"key":"10.1016\/j.imlet.2016.09.004_bib0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2005.05674.x","article-title":"Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases","volume":"130","author":"Panteli","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.imlet.2016.09.004_bib0025","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in good-risk chronic granulocytic leukemia","volume":"63","author":"Sokal","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2016.09.004_bib0030","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood-2010-12-319038","article-title":"Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score","volume":"118","author":"Hasford","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2016.09.004_bib0035","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/leu.2015.73","article-title":"The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries","volume":"29","author":"Hoffmann","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.imlet.2016.09.004_bib0040","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2014-07-590315","article-title":"TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets","volume":"125","author":"Yeung","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2016.09.004_bib0045","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imlet.2016.09.004_bib0050","article-title":"The IL-8\/IL-8R axis: a double agent in tumor immune resistance","volume":"4","author":"David","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.imlet.2016.09.004_bib0055","doi-asserted-by":"crossref","first-page":"E223","DOI":"10.1002\/ajh.23838","article-title":"Elevated soluble IL-2Ralpha, IL-8, and MIP-1beta levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma","volume":"89","author":"Sonbol","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.imlet.2016.09.004_bib0060","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2010-01-262071","article-title":"Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia","volume":"116","author":"Kornblau","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2016.09.004_bib0065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4161\/onci.19788","article-title":"Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8\/IL-8 and CXCL10\/IP-10","volume":"1","author":"Vujanovic","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.imlet.2016.09.004_bib0070","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1158\/1078-0432.CCR-05-0798","article-title":"Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment","volume":"11","author":"Kuroda","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imlet.2016.09.004_bib0075","first-page":"265","article-title":"Live cell vaccines expressing B7.1, monocyte chemoattractant protein 1 and granulocyte-macrophage colony stimulation factor derived from mouse HPV16-transformed cells","volume":"32","author":"Lakatosova-Andelova","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.imlet.2016.09.004_bib0080","first-page":"S63","article-title":"Role of TGF-beta3 in the regulation of immune responses","volume":"33","author":"Okamura","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2016.09.004_bib0085","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/sj.bjc.6600874","article-title":"Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis","volume":"88","author":"Li","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.imlet.2016.09.004_bib0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10585-012-9494-0","article-title":"Expression of TGFbeta3 and its effects on migratory and invasive behavior of prostate cancer cells: involvement of PI3-kinase\/AKT signaling pathway","volume":"30","author":"Walker","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.imlet.2016.09.004_bib0095","first-page":"890","article-title":"Naringenin: a partial agonist on estrogen receptor in T47D-KBluc breast cancer cells","volume":"6","author":"Kim","year":"2013","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.imlet.2016.09.004_bib0100","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2016.09.004_bib0105","doi-asserted-by":"crossref","first-page":"1520136","DOI":"10.1155\/2016\/1520136","article-title":"Exogenous heparan sulfate enhances the TGF-beta3-induced chondrogenesis in human mesenchymal stem cells by activating TGF-beta\/smad signaling","volume":"2016","author":"Chen","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.imlet.2016.09.004_bib0110","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/leu.2016.34","article-title":"TGF-alpha and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy","volume":"30","author":"Nievergall","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.imlet.2016.09.004_bib0115","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1586\/1744666X.2015.1019474","article-title":"Immunology of chronic myeloid leukemia: current concepts and future goals","volume":"11","author":"Vonka","year":"2015","journal-title":"Expert Rev. Clin. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781630178X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781630178X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:18:56Z","timestamp":1601083136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524781630178X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":23,"alternative-id":["S016524781630178X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2016.09.004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive value of serum cytokine levels in chronic myeloid leukemia patients","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2016.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}